US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Turkana Food Inc. Recall Flora Dried Apricots with Undeclared Sulfites on Product Labeling Because of Possible Health Risk

      Summary Company Announcement Date: June 12, 2025 FDA Publish Date: June … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / SSRI / Antidepressant Withdrawal: Are the Benefits Worth the Risk of Dependence?

Antidepressant Withdrawal: Are the Benefits Worth the Risk of Dependence?

April 17, 2018 By Lynn Shapiro Leave a Comment

Antidepressant

After a New York Times story written last week detailed the ravages of anti-depressant withdrawal, US Recall News spoke to a Manhattan psychopharmacologist and several New York City patients who are taking antidepressants–or have weaned themselves off of them–to find out whether the drugs’ benefits are worth the price of withdrawal.

We also spoke to a patient who is taking both testosterone and pot to combat his anxiety and depression.

The New York Times says “long-term use of antidepressants is surging in the United States.

Some 15.5 million Americans have been taking the medications for at least five years. The rate has almost doubled since 2010, and more than tripled since 2000.”

About 25 million adults have been taking antidepressants for at least two years, a 60 percent increase since 2010, The Times reports.

Cymbalta, Effexor and Paxil

Dr. David Gandler, a New York City psychopharmacologist, says the worst offenders–Cymbalta, Effexor and Paxil–leave the system quickly.

They can cause a rebound effect, known by the euphemism: “antidepressant discontinuation syndrome”, instead of by “addiction”, a term doctors are hesitant to use when speaking about anti-depressants.

Dr. Gandler says symptoms of withdrawal include:

  • Anxiety
  • Depression
  • Lightheadedness
  • Electric shock sensations known as “zaps”

Other symptoms listed on the web were: tiredness and flu-like symptoms.

Patients’ Stories

The first patient I spoke to was a 21-year old woman in Dr. Gandler’s waiting room.

She was beautiful and intelligent, but the sadness in her eyes hinted at depression.

She said she benefits from medication but is concerned about taking antidepressants during her child-bearing years, when I specifically showed her a story I wrote on pregnant women taking psychotropics.

“I want kids and I’m worried about that,” she confided.

“I’ve also felt drug withdrawal,” she added, regarding the Times story I brought into the office.

“But when a drug is working for me, I can focus better and be happier and more creative.”

Matt’s Solution: Testosterone

Matt, a 56-year old New Yorker, once ran the bond operations desk at a Wall Street brokerage.

However, he currently receives social security disability benefits, including Medicare, as his chronic depression has made working at his high-finance job impossible.

He says he recently found out his testosterone levels are lower than normal–a condition called hypogonadism–that can cause lack of energy, depression, loss of muscle mass and weight gain.

Since starting testosterone therapy last fall, Matt says he not only feels better; he has shed 30 pounds, as his appetite has been diminished.

Although he knows testosterone can cause blood clots, stroke, and may promote prostate cancer, he says: “I don’t care.”

“It makes my brain operate the way it did when I was younger and I no longer suffer with endless weight issues.”

Matt checks in regularly with his urologist who gives him the testosterone to make sure his PSA levels- a marker of prostate cancer-don’t increase.

Stopping testosterone treatment can also result in withdrawal symptoms, including depression and hot flashes.

Matt says his victory over his mental illness has been hard won.

“I’ve been on psychiatric medications for over 25 years.”

“I can remember three specific times trying to get off a cocktail of medications and having suicidal thoughts and severe depression and anxiety, and I’m not usually suicidal.

“I believe my brain has become dependent on these drugs.”

Matt continues to take his Prozac and Abilify cocktail, along with his testosterone, called Androgel, and also swears by marijuana as first-line treatment for his depression.

He doesn’t drink, as he says his father, also depressed, was an alcoholic until his untimely death.

The two illnesses are related, as depressed and anxious people often drink to numb their psychic pain.

Instant Suicide Patrol

Sai, a 53 year old man living in Ridgewood, N.J., has weaned himself off his Lexapro and feels less anxious than when he was on it.

Sai calls drug withdrawal: “Instant Suicide Patrol.”

“You want to kill yourself,” he says of his Lexapro withdrawal.  Lexapro is a short-acting drug, so it’s likely to cause a severe rebound if not slowly tapered.

Parked on Drugs

Dr. Gandler says the more episodes of depression a patient experiences, the harder it is to cure it.

The Catch 22 is: you’re at higher risk for major depression by going off your antidepressant and suffering another episode than by maintaining the dose you’re on.

Addressing this issue, Dr. Anthony Kendrick, a primary care professor at the University of Southampton, in the UK, told the New York Times, “that some people are essentially being parked on those drugs for convenience sake because it’s difficult to tackle the issue of taking them off.”

“Should we really be putting so many people on antidepressants long-term when we don’t know it’s good for them, or whether they’ll be able to come off?”, Dr. Kendrick asked.

Cannabis for Anxiety and Depression

It’s an open secret that pot works wonders for social anxiety disorder as well as for depression and post-traumatic stress disorder (PTSD) in veterans, but until lately, pot was considered a deviant drug.

That perception is changing as one state after another legalizes marijuana.

And as Bob Dylan said, the times are changing as former Speaker of the House, John Boehner announced last week he’s joining the Board of Acreage Holdings, a multi-state cannabis company, according to CNN.

“I’m joining the board of #AcreageHoldings because my thinking on cannabis has evolved,” the Ohio Republican tweeted.

“I’m convinced de-scheduling the drug is needed so we can do research, help our veterans [suffering from PTSD] and reverse the opioid epidemic ravaging our communities.”

Former Republican Massachusetts Gov. Bill Weld is also joining the board, CNN reports.

And since pot leaves your body very slowly, sometimes persisting for a month or more, it is the least likely anti-depressant and anxiolytic to cause physical dependence.

We’re looking forward to seeing Cynthia Nixon further confront Gov. Andrew Cuomo on his refusal to legalize marijuana during the mid-term election, as she’s made his resistance to legalize pot her signature campaign issue.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: Safety News, SSRI

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting
Accident Attorneys

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Turkana Food Inc. Recall Flora Dried Apricots with Undeclared Sulfites on Product Labeling Because of Possible Health Risk

June 12, 2025 By The FDA

Vita-Warehouse Corp. Issues Allergy Alert on Undeclared Peanut Allergen in ALDI Welby®, Berkley Jensen®, and VitaGlobe™ Vitamin B12 Gummy Products

June 12, 2025 By The FDA

Bugaboo North America Recalls Giraffe High Chairs Due to Risk of Serious Injury or Death from Fall Hazard

June 11, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Mammut Sports Group Recalls Skywalker Pro Via Ferrata Sets Due to Risk of Serious Injury or Death from Fall Hazard

June 11, 2025 By The CPSC

Endless Pools Recalls Manual Retractable Pool Covers Due to Drowning and Entrapment Hazards; Risk of Serious Injury and Death

June 11, 2025 By The CPSC

TTI Outdoor Power Equipment Recalls RYOBI 40-Volt 24-Inch Cordless Hedge Trimmers Due to Laceration Hazard

June 11, 2025 By The CPSC

Medtronic Announces Voluntary Recall of Select Newport™ HT70 and Newport™ HT70 Plus Ventilators and Certain Related Newport™ Service Parts

June 11, 2025 By The FDA

Hofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk

June 11, 2025 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Medtronic Announces Voluntary Recall of Select Newport™ HT70 and Newport™ HT70 Plus Ventilators and Certain Related Newport™ Service Parts

June 11, 2025 By The FDA

Hofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk

June 11, 2025 By The FDA

Bornstein Seafoods Inc Recalls Cooked & Peeled Ready-To-Eat Coldwater Shrimp Meat Because of Possible Health Risk

June 10, 2025 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Turkana Food Inc. Recall Flora Dried Apricots with Undeclared Sulfites on Product Labeling Because of Possible Health Risk
  • Vita-Warehouse Corp. Issues Allergy Alert on Undeclared Peanut Allergen in ALDI Welby®, Berkley Jensen®, and VitaGlobe™ Vitamin B12 Gummy Products
  • Bugaboo North America Recalls Giraffe High Chairs Due to Risk of Serious Injury or Death from Fall Hazard
  • Agro Superior Group Recalls Oliver & Smith Mattresses Due to Risk of Serious Injury or Death from Fire Hazard; Violation of Federal Standard for Mattress Flammability
  • More than One Million Anker Power Banks Recalled Due to Fire and Burn Hazards; Manufactured by Anker Innovations
  • Mammut Sports Group Recalls Skywalker Pro Via Ferrata Sets Due to Risk of Serious Injury or Death from Fall Hazard
  • Endless Pools Recalls Manual Retractable Pool Covers Due to Drowning and Entrapment Hazards; Risk of Serious Injury and Death
  • TTI Outdoor Power Equipment Recalls RYOBI 40-Volt 24-Inch Cordless Hedge Trimmers Due to Laceration Hazard
  • Medtronic Announces Voluntary Recall of Select Newport™ HT70 and Newport™ HT70 Plus Ventilators and Certain Related Newport™ Service Parts
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in